FHI vs HOMB
Federated Hermes vs Home BancShares — AI-powered side-by-side comparison
FHI
Federated Hermes
71
Buy
VS
HOMB
Home BancShares
73
Buy
| Metric | FHI | HOMB |
|---|
| AI Score |
71
|
73
|
| Price |
$63.95
|
$30.41
|
| P/E Ratio |
11.74×
|
12.69×
|
| ROE |
33.7%
|
11.1%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
71.6%
|
78.5%
|
| Debt / Equity |
0.36×
|
0.20×
|
| Dividend Yield |
2.3%
|
2.8%
|
| RSI (14) |
65.9
|
48.8
|
| Beta |
0.627
|
0.676
|
| Expected Upside |
—
|
+0.8%
|
AI Committee View
Current Innellis committee reasoning for FHI versus HOMB.
HOMB leads by 2 points.
HOMB scores 73/100 (Buy) versus FHI at 71/100 (Buy).
FHI Committee View
100% agreement
6 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is sector concentration is already high (hhi 2974.99). The committee is constructive but not yet at full conviction.
Bull Case
- P/E of 11.5 is inexpensive for the broad market — Value
- ROE of 34.0% shows genuine earnings power backing the valuation — Value
- Dividend yield of 3.5% pays you to wait — Value
Bear Case
- RSI at 72 is in overbought territory — Technical
- Weekly RSI at 75 -- overbought on the larger timeframe too — Technical
- Bollinger bandwidth of 17.1% signals elevated volatility — Risk
HOMB Committee View
83% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- P/E of 13.0 is inexpensive for the broad market — Value
- Price-to-book of 1.3x is a discount to asset value — Value
- Dividend yield of 3.3% pays you to wait — Value
Bear Case
- MACD histogram negative -- bearish momentum — Technical